Many stem cell therapy providers still harvest mesenchymal stem cells from bone marrow which involves drilling a hole usually in the patient’s hip bone and using a syringe to extract bone marrow. Most of the stem cells found in bone marrow are hematopoietic stem cells that become red blood cells, platelets, or white blood cells. Mesenchymal stem cell counts in bone marrow are less than 10,000 per 2 ounces of bone marrow.
Purchasing and using cryopreserved, (frozen) umbilical cord stem cells is another popular option with many stem cell therapy providers. However, there are numerous undesirable aspects of cryopreservation that lead to possible genetic and epigenetic changes, and low cell survival rates.
At Pangenics Regenerative Center our stem cell physicians use a 38-step process to harvest up to 50 million live mesenchymal stem cells from a patient’s adipose tissue, (body fat), isolate and enrich the harvested cells with platelet rich plasma, and then injecting live, viable mesenchymal stem cells directly into the damaged joint and also intravenously.
Therapy begins with a small amount of body fat that is collected with the Adivive FDA approved fat transfer system under local anesthetic. In this first step we collect adipose tissue, (fat) that is rich with mesenchymal stem cells and retrieve what we refer to as Stromal Vascular fraction, (SVF):